北京大学学报(医学版) ›› 2016, Vol. 48 ›› Issue (6): 958-963. doi: 10.3969/j.issn.1671-167X.2016.06.007

• 论著 • 上一篇    下一篇

不同亚型的滤泡辅助性T淋巴细胞在类风湿关节炎中的临床意义

陈晓梅1,2*,李静1*,张晓盈1,金月波1,余迪1,孙晓麟1,武丽君2△,何菁1△,栗占国1   

  1. (1. 北京大学人民医院风湿免疫科, 北京100044; 2. 新疆维吾尔自治区人民医院风湿免疫科, 乌鲁木齐830001)
  • 出版日期:2016-12-18 发布日期:2016-12-18
  • 通讯作者: 武丽君,何菁 E-mail:wwlj330@126.com,hejing1105@126.com
  • 基金资助:

    国家自然科学基金(81373117, 81429003)资助

Significance of different T follicular helper subsets in rheumatoid arthritis

CHEN Xiao-mei1,2*, LI Jing1*, ZHANG Xiao-ying1, JIN Yue-bo1, YU Di1, SUN Xiao-lin1,WU Li-jun2△, HE Jing1△, LI Zhan-guo1   

  1. (1. Department of Rheumatology and Immunology, Peking University People’s Hospital, Beijing, 100044, China; 2. Department of Rheumatology and Immunology, The People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, 830001, China)
  • Online:2016-12-18 Published:2016-12-18
  • Contact: WU Li-jun, HE Jing1 E-mail:wwlj330@126.com,hejing1105@126.com
  • Supported by:

    Supported by the National Natural Science Foundation of China (81373117, 81429003)

摘要:

目的:检测类风湿关节炎(rheumatoid arthritis, RA)患者外周血中滤泡辅助性T(T follicular helper, Tfh)淋巴细胞亚型以及效应型滤泡辅助性T(T follicular helper effector memory, Tfhem)细胞的表达,并探讨二者作为活动性RA患者血液标志物的价值。方法: 流式细胞术分别检测41例RA患者和32例健康受试者的外周血中Tfh(CD3+CD4+CXCR5+CD45RA-)细胞亚型 Tfh1(CXCR3+CCR6-Tfh)、Tfh2(CXCR3-CCR6-Tfh)、Tfh17(CXCR3-CCR6+Tfh)和Tfhem (CD4+CXCR5+CCR7lowPD-1high)的水平。收集入组RA患者的临床资料及实验室指标,分析上述细胞亚型表达水平与RA疾病活动和实验室指标的相关性,酶联免疫吸附法(enzyme-linked immunosorbent, ELISA)检测相关血清细胞因子。结果: RA患者外周血中Tfhem细胞的表达率明显高于正常对照组(12.8%±5.7% vs. 8.7%±2.0%, P=0.001)。Tfhem细胞表达水平与RA患者疾病活动指数(disease activity score in 28 joints, DAS28)及红细胞沉降率(erythrocyte sedimentation rate, ESR)存在显著相关性(r(DAS28)=0.205, r(ESR)=0.141,P<0.05),与抗角蛋白抗体(anti-keratin antibody,AKA)、抗核周因子(anti-perinuclear factor, APF)及IgM型类风湿因子(immunoglobulin Mrheumatoid factors,IgM-RF)、IgA、IgM及IgG等临床指标则无明显相关性。Tfh2表达水平在RA组显著高于正常对照组(3.002%±0.408% vs. 1.730%± 0.160%, P=0.013)。Tfh2-high组RA患者的IgA[(3.045±0.261)g/L vs.(3.963±0.815) g/L,P=0.172]、IgG[(13.800±0.862)g/L vs.(16.980±0.224) g/L,P=0.161]和IgM[(1.135±0.083)g/L vs.(1.731±0.380) g/L,P=0.140]高于Tfh2low组,但差异尚无统计学意义(P>0.05)。与Tfh低表达组相比,Tfh2高表达组血清中IL-4[(2.322±0.214)ng/L vs. (3.994±0.751) ng/L, P=0.056]和IL10[(1.898±0.105) ng/L vs. (3.125±0.880) ng/L, P=0.140]升高,差异无统计学意义(P>0.05)。结论: Tfhem细胞的表达与RA患者病情活动有关,可能在RA的发病过程中有预警作用,并可能成为将来治疗RA的靶细胞;Tfh2及其相关细胞因子在RA患者中明显增加,可能参与了RA的发生和发展。

关键词: 关节炎, 类风湿, T淋巴细胞, 辅助诱导, 疾病活动指数

Abstract:

Objective: To detect the expressions of T follicular helper (Tfh) subsets and T follicular helper effect memory (Tfhem) cells in circulation of patients with rheumatoid arthritis (RA), as well as to examine their roles in providing biomarkers for active RA. Methods: This study enrolled 41 patients with RA, who were na-vely-treated or had no application of hormone and disease-modifying anti-rheumatic drugs in recent 3 months, as well as 32 healthy controls. The percentages of Tfhem (CD4+CXCR5+CCR7lowPD1high) cells, Tfh (CD3+CD4+CXCR5+CD45RA-) subsets, Tfh1 (CXCR3+CCR6-Tfh),Tfh2 (CXCR3-CCR6-Tfh),and Tfh17 (CXCR3-CCR6+Tfh), were determined by flow cytometry of peripheral blood from the patients with RA and health controls. Serum levels of cytokines were detected by enzyme-linked immunosorbent (ELISA). The correlations of Tfhem/Tfh subsets with clinical indicators were analyzed. Results: The mean age of the patients was (56.1±14.0) years (range: 20-82 years), the mean disease duration was (8.2±8.1) years. There was no significant difference between the RA patients and the health controls with age and gender. As compared with the health control, the percentage of Tfhem was significantly increased in the peripheral blood of the RA patients (12.8%±5.7% vs. 8.7%±2.0%, P=0.001). Moreover, the increased Tfhem was correlated with the higher disease activity score in 28 joints (DAS28) and erythrocyte sedimentation rate (ESR), but not with other clinical indicators, such as C-reactive protein (CRP), anti-cyclic citrullinated peptide (CCP) antibodies, and rheumatoid factors (RF). In addition, the percentage of Tfh2 subset, but not Tfh1 or Tfh17, was significantly increased in the RA patients (3.002%±0.408% vs. 1.730%±0.160%, P=0.013). As compared with Tfh2-low group, serum levels of Ig (immunoglobulin) A [(3.045±0.261) g/L vs.(3.963±0.815) g/L, P=0.172], IgG [(13.800±0.862) g/L vs.(16.980±0.224) g/L, P=0.161], IgM [(1.135±0.083) g/L vs.(1.731±0.380) g/L, P=0.140], IL (interleukin)-4 [(2.322±0.214) ng/L vs.(3.994±0.751) ng/L, P=0.056] and IL-10[(1.898±0.105) ng/L vs. (3.125±0.880) ng/L, P=0.140] in Tfh2-high group tended to increase with no significant statistical difference. Conclusion: Our data suggest that Tfhem is associated with disease activity and is a va-luable marker for active RA. It also presents a potential pathogenesis in the development of RA and the target for future therapies. Meanwhile, the increased Tfh2 and associated cytokines might be involved in the development of RA.

Key words: Arthritis, rheumatoid, T-lymphocytes, helper-inducer, Disease activity score

中图分类号: 

  • R593.22
[1] 魏慧, 张警丰, 姚中强, 赵金霞. 类风湿关节炎合并慢性病贫血患者的临床特征及相关因素[J]. 北京大学学报(医学版), 2026, 58(2): 307-312.
[2] 吴滔, 林建子, 朱亚锋, 马剑达, 贾霈雯, 杨莉娟, 潘婕, 邹耀威, 杨迎, 卢烨, 戴冽. 血清蛋白质谱筛选及验证类风湿关节炎患者肌肉量减少的生物标志物[J]. 北京大学学报(医学版), 2025, 57(6): 1024-1031.
[3] 王翠萍, 陈哲, 程永静. 超微血流成像评估与膝骨关节炎临床症状的关联研究[J]. 北京大学学报(医学版), 2025, 57(6): 1096-1100.
[4] 吕雪冰, 俞烜华, 张伟桢, 刘昌泉, 林互涵, 曾珊婷, 黄惠娟, 吴月萍. 类风湿关节炎合并坏死性筋膜炎1例[J]. 北京大学学报(医学版), 2025, 57(6): 1198-1202.
[5] 丁艳, 王丽芳, 李超然, 卢哲敏, 石连杰. 利妥昔单抗成功治疗类风湿关节炎合并IgG4相关性疾病1例[J]. 北京大学学报(医学版), 2025, 57(6): 1203-1207.
[6] 杨菊, 徐婧, 戴菊华, 石连杰. Lumican蛋白在类风湿关节炎患者血清中的表达及其与疾病和免疫活动的相关性[J]. 北京大学学报(医学版), 2025, 57(5): 911-918.
[7] 冯亮华, 洪丽荣, 陈雨佳, 蔡学明. 泛素特异性蛋白酶35对类风湿关节炎成纤维样滑膜细胞铁死亡的作用及机制[J]. 北京大学学报(医学版), 2025, 57(5): 919-925.
[8] 贾霈雯, 杨迎, 邹耀威, 欧阳志明, 林建子, 马剑达, 杨葵敏, 戴冽. 类风湿关节炎患者低肌肉量综合征的临床特征及其对躯体功能的影响[J]. 北京大学学报(医学版), 2024, 56(6): 1009-1016.
[9] 马豆豆, 卢哲敏, 郭倩, 朱莎, 古今, 丁艳, 石连杰. 小剂量利妥昔单抗成功治疗类风湿关节炎合并重症肌无力1例[J]. 北京大学学报(医学版), 2024, 56(6): 1110-1114.
[10] 蔡文心, 杨琼英, 韩丹, 陈哲, 程永静. 红外热成像检查在风湿病中的应用及展望[J]. 北京大学学报(医学版), 2024, 56(6): 1132-1136.
[11] 闫蕊, 柯丹, 张妍, 李丽, 苏焕然, 陈伟, 孙明霞, 刘晓敏, 罗靓. 血清趋化因子CXCL-10和涎液化糖链抗原6水平在类风湿关节炎合并肺间质病变患者中的诊断和病情评估价值[J]. 北京大学学报(医学版), 2024, 56(6): 956-962.
[12] 赵亮, 史成龙, 马柯, 赵静, 王潇, 邢晓燕, 莫万星, 练益瑞, 高超, 李玉慧. 抗合成酶综合征重叠类风湿关节炎患者的免疫学特征[J]. 北京大学学报(医学版), 2024, 56(6): 972-979.
[13] 翟佳羽, 赵金霞, 安卓, 刘蕊. 低疾病活动度的中轴型脊柱关节炎患者残留症状评估及其相关因素分析[J]. 北京大学学报(医学版), 2024, 56(6): 987-993.
[14] 韩艺钧, 陈小莉, 李常虹, 赵金霞. 甲氨蝶呤在类风湿关节炎患者中的应用现状[J]. 北京大学学报(医学版), 2024, 56(6): 994-1000.
[15] 刘东武, 陈杰, 高明利, 于静. 类风湿关节炎伴发淋巴结Castleman样病理改变1例[J]. 北京大学学报(医学版), 2024, 56(5): 928-931.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!